North America Thrombectomy Devices Market

North America Thrombectomy Devices Market Size (2022 to 2027)

The size of the North America Thrombectomy Devices Market was valued at USD 0.41 billion in 2022. It is further estimated to be growing at a CAGR of 7.9% and worth USD 0.60 billion by 2027.

The Thrombectomy Devices procedures which are commonly used are balloon embolectomy, aspiration embolectomy, and surgical embolectomy. In the aspiration embolectomy procedure, the thrombus is taken out by using suction instead of a balloon. It is thought of as a quick and effective way of removing thrombi in limb arteries. In the Balloon embolectomy, the catheter is inserted, which has an inflatable balloon at its tip. It is inserted into a blood clot and inflated, and then the balloon is removed along with the clot. Risks involved in the procedure are intimal lesions, which can lead to another thrombosis. Surgical embolectomy removes the clot by surgical incision into an artery.

The driving factors of the North America Thrombectomy Devices market are increasing demand for minimally invasive procedures, increasing prevalence of cardiovascular diseases, rising sedentary lifestyle, growing geriatric population, and technological innovations in the medical field. The constraints faced by this market are difficulty in using new equipment, lack of skilled workers, and lack of awareness about peripheral vascular diseases. 

This research report on the North America Thrombectomy Devices Market has been segmented and sub-segmented into the following categories:

By Type:

• Stent Retrievers
• Basket/Brush Retrievers
• Coil Retrievers
• Mechanical Thrombectomy Devices
• Ultrasonic Thrombectomy Devices
• Aspiration Thrombectomy Devices
• Hydrodynamic Thrombectomy Devices

By Application:

• Peripheral Vascular Application
• Neurovascular Application
• Cardiovascular Application

By End Users: 

• Research Laboratories & Academic Institutes
• Ambulatory Surgical Centres
• Hospital Surgical Centres
• Others

By Disease: 

• Coronary Diseases
• Neural Diseases
• Peripheral Diseases

By Country: 

• The United States
• Canada
• Rest of North America

Geographically, the largest share is recorded by the United States in the region, which can be owed to many technologically advanced devices present in the country. Factors such as the rising geriatric population, increased incidence of cardiovascular diseases, and technological advancements in the medical field are expected to drive the market growth in the region.

Promising Companies dominating the North America Thrombectomy Devices Market Profiled in the Report are Stryker Corporation (U.S.), Medtronic Plc (U.S.), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.) Johnson & Johnson (U.S.), Terumo Corporation (Japan), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.).